Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Colorimetric Sensors for DNA

Fusion IP
A novel colorimetric sensor with properties which include detecting the presence of DNA.

Full description

This chemical compound can interact with DNA in a specific manner and undergoes a visible colour change; this specificity may be related to the sequence or, more likely, the structure of the target DNA.  The compound is a dinuclear Ruthenium-based coordination complex which can bind to DNA and undergoes a colour change from purple to green or blue depending upon the nature of the DNA.  

Some preliminary work suggests that the prototype molecule is not markedly cytotoxic and so could be used for research with live, rather than fixed, cells. 

A striking feature of the molecule is its apparent ability to specifically bind certain DNA structures, offering the possibility of the direct detection of these structures in living cells and the use of this compound as a tool for studying cell biology.

Development status

Early Stage

Patent information

We have filed a patent application on a family of compounds related to this molecule and their use in an array of possible applications.

Type of business relationship sought

There are an enormous range of possible applications for this technology and we are seeking commercial partners to develop particular applications of the molecule that utilise its ability to: 

  • Change colour depending on the presence of different DNA sequences/structures
  • Bind certain DNA structures preferentially
  • Enter living cells 

Further information is available on this opportunity under an appropriate confidentiality agreement.

Licensing contact

Dr Andrew Tingey
IP Pipeline Manager
Request more information

More information

For more information about the product please visit website.

Company details

Fusion IP
Fusion IP turn world class university research into business by investing in the world's most exciting science

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related categories

Partnering consultation free of charge
Pharmalicensing Jobs
Biotech Patents
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us